Bio
Mark Pegram, MD, is the Suzy Yuan-Huey Hung Endowed Professor of Medical Oncology at the Stanford University School of Medicine. He currently serves as the Associate Director of Clinical Research at the Stanford Comprehensive Cancer Institute (SCCI). He also serves as the Associate Dean for Clinical Research Quality at the Stanford University School of Medicine, and is the Medical Director of the Stanford Clinical Translational Research Unit ? a unit specializing in first-in-human phase I clinical trials
Dr Pegram received his medical degree from the University of North Carolina at Chapel Hill. He went on to complete an internship and residency at the University of Texas Southwestern Medical Center in Dallas. He concluded his training with a fellowship at the UCLA David Geffen School of Medicine in Los Angeles, CA.
Dr Pegram?s breast cancer research is focused on the study of the cancer-associated gene that encodes HER2 and on the development of novel agents in the treatment of patients with HER2-positive metastatic breast cancer. Dr Pegram has been educating other healthcare professionals about the future impact of biosimilars in oncology practice, especially in the breast cancer treatment landscape. He has authored more than 110 publications in medical oncology, hematology, and biosimilars across different cancer types.
Clinical Focus
- Cancer > Breast Cancer
- molecular therapeutics
- Medical Oncology
Academic Appointments
-
Professor - Med Center Line, Medicine - Oncology
-
Member, Bio-X
-
Member, Stanford Cancer Institute
Administrative Appointments
-
Medical Director of the Stanford Clinical Translational Research Unit, Stanford School of Medicine (2020 - Present)
-
Associate Dean for Clinical Research Quality, Stanford School of Medicine (2018 - Present)
-
Associate Director for Clinical Research, Stanford Cancer Institute (2013 - Present)
-
Director, Stanford Breast Oncology Program, Stanford Cancer Institute (2012 - 2019)
-
Co-Director, Translational Oncology Research Program @ Stanford (TOP@S), Stanford Cancer Institute (2013 - 2018)
Honors & Awards
-
Sylvester Outstanding Cancer Research Award, University of Miami Sylvester Comprehensive Cancer Center (13 May 2011)
-
6th Annual Connie Moskow Memorial Lectureship, Robert H. Lurie Comprehensive Cancer Center of Northwestern University (11 May 2012)
-
John G. Kuhn Lecture, Hematology/Oncology Pharmacy Association (21 March 2013)
-
Chair, Department of Defense Breast Cancer Research Program Integration Panel, Congressionally Directed Medical Research Programs, U.S. Army Research and Materiel Command (2012)
-
2012 Keynote Lecture, American Radium Society 94th Annual Meeting, American Radium Society (29 April 2012)
-
The Celebrity Cruises Award, The Breast Cancer Research Foundation (2013-2014)
Professional Education
-
Fellowship: UCLA Division of Hematology and Oncology (1993) CA
-
Residency: University of Texas Southwestern Internal Medicine Residency (1990) TX
-
Medical Education: University of North Carolina School of Medicine (1986) NC
-
Board Certification: American Board of Internal Medicine, Medical Oncology (1993)
-
Board Certification: American Board of Internal Medicine, Internal Medicine (1989)
Community and International Work
-
The 7th Princess Chulabhorn International Science Congress, Bangkok, Thailand
Topic
Cancer: From Basic Research To Cure
Partnering Organization(s)
Chulabhorn Research Institute
Location
International
Ongoing Project
No
Opportunities for Student Involvement
No